Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1483

1.

Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy.

Sindrup SH, Holbech J, Demant D, Finnerup NB, Bach FW, Jensen TS.

Eur J Pain. 2017 Sep;21(8):1443-1450. doi: 10.1002/ejp.1048. Epub 2017 May 30.

PMID:
28557178
2.

A randomized clinical trial comparing two two-phase treatment strategies for in-patients with severe depression.

Vermeiden M, Kamperman AM, Hoogendijk WJG, van den Broek WW, Birkenhäger TK.

Acta Psychiatr Scand. 2017 Jul;136(1):118-128. doi: 10.1111/acps.12743. Epub 2017 May 6.

PMID:
28478653
3.

Clonidine may have a beneficial effect on refractory nocturnal enuresis.

Ohtomo Y.

Pediatr Int. 2017 Jun;59(6):711-713. doi: 10.1111/ped.13269. Epub 2017 Apr 24.

PMID:
28235147
4.

The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover study.

Okkerse P, van Amerongen G, de Kam ML, Stevens J, Butt RP, Gurrell R, Dahan A, van Gerven JM, Hay JL, Groeneveld GJ.

Br J Clin Pharmacol. 2017 May;83(5):976-990. doi: 10.1111/bcp.13183. Epub 2017 Jan 9.

5.

Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression.

Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.

Int J Risk Saf Med. 2016 Sep 17;28(3):143-61. doi: 10.3233/JRS-160728.

6.

Reboxetine in therapy-resistant enuresis: A randomized placebo-controlled study.

Lundmark E, Stenberg A, Hägglöf B, Nevéus T.

J Pediatr Urol. 2016 Dec;12(6):397.e1-397.e5. doi: 10.1016/j.jpurol.2016.04.048. Epub 2016 Jul 12.

PMID:
27544904
7.

Restoring Study 329: Paroxetine neither effective nor safe for adolescents.

Mulder R, Rucklidge JJ, Toop L.

Aust N Z J Psychiatry. 2016 Sep;50(9):922-3. doi: 10.1177/0004867416657412. Epub 2016 Jul 7. No abstract available.

PMID:
27389067
8.

Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo-Controlled Trial.

Limsrivilai J, Charatcharoenwitthaya P, Pausawasdi N, Leelakusolvong S.

Am J Gastroenterol. 2016 Feb;111(2):217-24. doi: 10.1038/ajg.2015.413. Epub 2016 Jan 12.

PMID:
26753892
9.

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.

Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.

BMJ. 2015 Sep 16;351:h4320. doi: 10.1136/bmj.h4320.

10.

Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.

Siegenthaler A, Schliessbach J, Vuilleumier PH, Juni P, Zeilhofer HU, Arendt-Nielsen L, Curatolo M.

BMC Pharmacol Toxicol. 2015 Sep 16;16:23. doi: 10.1186/s40360-015-0023-z.

11.

S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.

Ambrée O, Bergink V, Grosse L, Alferink J, Drexhage HA, Rothermundt M, Arolt V, Birkenhäger TK.

Int J Neuropsychopharmacol. 2015 Sep 12;19(3):pyv103. doi: 10.1093/ijnp/pyv103.

12.

Accounting for Behavior in Treatment Effects: New Applications for Blind Trials.

Chassang S, Snowberg E, Seymour B, Bowles C.

PLoS One. 2015 Jun 10;10(6):e0127227. doi: 10.1371/journal.pone.0127227. eCollection 2015.

13.

Psychological stress and its relationship with persistent allergic rhinitis.

El Hennawi Del D, Ahmed MR, Farid AM.

Eur Arch Otorhinolaryngol. 2016 Apr;273(4):899-904. doi: 10.1007/s00405-015-3641-6. Epub 2015 May 8.

PMID:
25951791
14.

Gradual tapering of desmopressin leads to better outcome in nocturnal enuresis.

Ohtomo Y, Umino D, Takada M, Fujinaga S, Niijima S, Shimizu T.

Pediatr Int. 2015 Aug;57(4):656-8. doi: 10.1111/ped.12614. Epub 2015 May 27.

PMID:
25728739
15.

Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial.

Holbech JV, Bach FW, Finnerup NB, Brøsen K, Jensen TS, Sindrup SH.

Pain. 2015 May;156(5):958-66. doi: 10.1097/j.pain.0000000000000143.

PMID:
25719617
16.

Testing an mHealth momentary assessment Routine Outcome Monitoring application: a focus on restoration of daily life positive mood states.

van Os J, Delespaul P, Barge D, Bakker RP.

PLoS One. 2014 Dec 16;9(12):e115254. doi: 10.1371/journal.pone.0115254. eCollection 2014.

17.

Early improvement as a predictor of eventual antidepressant treatment response in severely depressed inpatients.

Vermeiden M, Kamperman AM, Vulink ME, van den Broek WW, Birkenhäger TK.

Psychopharmacology (Berl). 2015 Apr;232(8):1347-56. doi: 10.1007/s00213-014-3765-1. Epub 2014 Oct 23.

PMID:
25338776
18.

Medication effects on periurethral sensation and urethral sphincter activity.

Greer WJ, Gleason JL, Kenton K, Szychowski JM, Goode PS, Richter HE.

Female Pelvic Med Reconstr Surg. 2015 Mar-Apr;21(2):77-82. doi: 10.1097/SPV.0000000000000133.

19.

Potassium channel ether à go-go1 is aberrantly expressed in human liposarcoma and promotes tumorigenesis.

Wu J, Zhong D, Wei Y, Wu X, Kang L, Ding Z.

Biomed Res Int. 2014;2014:345678. doi: 10.1155/2014/345678. Epub 2014 Jul 20.

20.

Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.

Baldwin DS, Green M, Montgomery SA.

Int Clin Psychopharmacol. 2014 Nov;29(6):339-43. doi: 10.1097/YIC.0000000000000042.

PMID:
24859491

Supplemental Content

Loading ...
Support Center